All News

Hand massage was proven to not only reduce patient anxiety while undergoing chemotherapy, but also to strengthen nurse-patient relationships.

Algenpantucel-L failed to improve OS for patients with pancreatic cancer in a phase 3 trial.

While there have been many recent groundbreaking advances in treating myeloma, Kenneth C. Anderson is optimistic that the future holds even more promise.

Insomnia can be a problem for many patients with breast cancer.

I am typing this as I wait to be called back for scans. The miracle of imaging and the advances that have been made in the 17 years since my diagnosis do not escape me. I will soon receive the results that will determine my next steps. I will never meet or know all of the people that it takes to create these images, to read the results, or even to help make important choices in moving forward.

In an interview with Hyman B. Muss, CURE gained insight into the complications, misconceptions and likely outcomes of patients who are simultaneously pregnant and battling breast cancer.

The FDA expanded the label for Imbruvica for some patients with CLL, as the drug continues to show improved survival benefits.

A recent phase 3 trial is exploring the question of whether or not smoldering multiple myeloma needs treatment.

A new three-drug combination is proving successful for patients with relapsed/refractory multiple myeloma, according to a phase 3 study.

Even those without the diagnosis have a lot to learn from cancer.

My dog helped me get through cancer and now my heart is breaking.

Stivarga (regorafenib) proved to have better overall survival for patients with HCC in a recent phase 3 trial.

“This is a small-site, single-arm study, but these preliminary data are encouraging,” says lead study author Roberto Pili. “It suggests that this combination of an HDAC inhibitor can induce a greater benefit with an immunotherapy — in this case, IL-2.”

Although it is often a sensitive topic to discuss, being obese puts women at a higher risk for developing — and dying from— endometrial cancer.

Despite advances in treatment for bladder cancer and RCC, there is still an unmet need for navigating biomarkers that will offer insight as to which patients will respond best to treatment.

Those of us touched by cancer know all too well that the stages of grief are not linear—not steps we move along with the precise choreography of ballet dancers.

A long-time stage magician and cancer survior shares a few tricks

A life-saving therapy for patients with prostate cancer may cause clinical depression, according to a recent study.

Oncology nurses should use evidence-based symptom interventions, such as exercise, to help their patients manage side effects like anxiety and fatigue.

“There are a lot of drugs, many targets, and still no cures,” says Figlin. “There is still an unmet need, despite the plethora of agents that have been approved in this space.”

The FDA granted olaratumab a priority review for some people with advanced soft tissue sarcoma (STS).

The FDA granted Blincyto a priority review for certain pediatric patients with ALL.

Writing about this disease helps me heal.

Perspective matters when confronting what the future holds.

A recent study showed not only that it is possible to administer chemotherapy in an outpatient setting, but it also can improve patients' quality of life and save money.

Nightly fasting could reduce breast cancer recurrence, according to a study that looked at more than 2,400 women with early-stage breast cancer.

Lynch syndrome is an inherited cancer susceptibility syndrome caused by mutations in one of five DNA mismatch repair (MMR) genes.

Cancer surviving caregiver strives to support her mom through cancer.

As oral cancer treatments continue to be used more frequently, nurses must be able to know that patients are following their regimen.

One oncology nurse took action to address skin toxicities associated with EGFR-inhibitor (EGFRI) targeted therapies.